[Proton beam radiotherapy of uveal melanoma--preliminary results]
- PMID: 23373396
[Proton beam radiotherapy of uveal melanoma--preliminary results]
Abstract
Purpose: Presentation of the proton beam radiotherapy (PBR) as a method of treatment of the uveal melanoma patients in the Department of Ophthalmology and Ocular Oncology and Nuclear Physics Institute in Cracow, Poland and their preliminary results.
Material and methods: Nine patients with only choroidal melanoma were treated using PBR between January and April 2011. There were 4 women (44%) and 5 men (56%), a mean age 56 years (38-72). The mean tumor thickness using ultrasounds was 4.14 mm (1.4-9.6 mm).
Results: The mean follow-up was 6 months (5-7). The mean tumor thickness after PBR was 2.47 mm (0-9.3 mm). In 2 patients endoresection of irradiated tumor mass was performed with final flat scar. After exclusion of these patients from analysis, the mean thickness was 3.17 mm (1.5-9.3 mm). In 6 patients the visual function was stable.
Conclusions: The preliminary results show that PBR is highly precise method of uveal melanoma treatment achieving high rates of local control. This method necessitates a close co-operation between ophthalmologist, oncologist, radiotherapists, and medical physicist as well as an elaboration of own procedures of planning and treatment. uveal melanoma, radiotherapy, proton-beam radiotherapy.
Similar articles
-
Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.Arch Ophthalmol. 2006 Jun;124(6):838-43. doi: 10.1001/archopht.124.6.838. Arch Ophthalmol. 2006. PMID: 16769837
-
Proton beam therapy for the treatment of uveal melanoma in Scotland.Br J Ophthalmol. 2011 Dec;95(12):1691-5. doi: 10.1136/bjo.2010.195594. Epub 2011 Jan 7. Br J Ophthalmol. 2011. PMID: 21216794
-
[Endoresection following proton beam irradiation of large uveal melanomas].Ophthalmologe. 2004 Apr;101(4):370-6. doi: 10.1007/s00347-003-0911-2. Ophthalmologe. 2004. PMID: 15067418 German.
-
Eye retention after proton beam radiotherapy for uveal melanoma.Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):867-80. doi: 10.1016/s0360-3016(02)04200-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 12605964 Review.
-
Uveal melanoma: proton beam irradiation.Ophthalmol Clin North Am. 2005 Mar;18(1):111-8, ix. doi: 10.1016/j.ohc.2004.08.002. Ophthalmol Clin North Am. 2005. PMID: 15763196 Review.
Cited by
-
Outcomes of I-125 brachytherapy for uveal melanomas depending on irradiation dose applied to the tumor apex - a single institution study.J Contemp Brachytherapy. 2018 Dec;10(6):532-541. doi: 10.5114/jcb.2018.79886. Epub 2018 Dec 28. J Contemp Brachytherapy. 2018. PMID: 30662476 Free PMC article.
-
Transplantable Melanomas in Hamsters and Gerbils as Models for Human Melanoma. Sensitization in Melanoma Radiotherapy-From Animal Models to Clinical Trials.Int J Mol Sci. 2018 Apr 1;19(4):1048. doi: 10.3390/ijms19041048. Int J Mol Sci. 2018. PMID: 29614755 Free PMC article. Review.
-
Radiation treatment methods in uveal melanoma.Med Hypothesis Discov Innov Ophthalmol. 2021 May 31;10(1):32-42. doi: 10.51329/mehdiophthal1419. eCollection 2021 Spring. Med Hypothesis Discov Innov Ophthalmol. 2021. PMID: 37641625 Free PMC article. Review.
-
Analysis of local recurrence causes in uveal melanoma patients treated with 125I brachytherapy - a single institution study.J Contemp Brachytherapy. 2019 Dec;11(6):554-562. doi: 10.5114/jcb.2019.90985. Epub 2019 Dec 16. J Contemp Brachytherapy. 2019. PMID: 31969914 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous